FGFR1 and early-onset autosomal dominant Alzheimer disease: In addition, FGF2/FGFR1 signaling could regulate inflammation of hippocampus to exert a positive effect on some neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and traumatic brain injury (Woodbury and Ikezu, 2014).